Evidence map›Paper›PMID 33156493›Full record

ArticleEndocrine2021

Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study.

Emmanuelle Kuhn, Philippe Caron, Brigitte Delemer, Isabelle Raingeard, Hervé Lefebvre, Gérald Raverot, Christine Cortet-Rudelli, Rachel Desailloud, Clementine Geffroy, Robin Henocque and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Emmanuelle KuhnAssistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94275, Le Kremlin-Bicêtre, France.
Philippe CaronCHU de Toulouse, Hôpital Larrey, 24 Chemin de Pouvourville, TSA 30030, 31059, Toulouse Cedex 9, France.
Brigitte DelemerCHU de Reims-Hôpital Robert Debré, Avenue du Général Koenig, 51092, Reims Cedex, France.
Isabelle RaingeardCHRU de Montpellier, Maladies Endocriniennes, Hopital Lapeyronie, 295 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France.
Hervé LefebvreCHU de Rouen, 1 Rue de Germont, 76031, Rouen Cedex, France.
Gérald RaverotHospices civils de Lyon, Hôpital Louis Pradel, 59 Boulevard Pinel, 69677, Bron Cedex, France.
Christine Cortet-RudelliCHR Lille, Hôpital Claude Huriez, Rue Michel Polonovski, 59037, Lille, France.
Rachel DesailloudCHU d'Amiens, Hôpital Nord, Place Victor Pauchet, 80054, Amiens Cedex 1, France.
Clementine GeffroyPfizer France, 23-25 Avenue du Docteur Lannelongue, 75668, Paris Cedex 14, France.
Robin HenocquePfizer France, 23-25 Avenue du Docteur Lannelongue, 75668, Paris Cedex 14, France.
Yves BraultPfizer France, 23-25 Avenue du Docteur Lannelongue, 75668, Paris Cedex 14, France.
Thierry BrueCHU de Marseille, Hôpital de la Conception, 147 boulevard Baille, 13385, Marseille Cedex 5, France.
Philippe ChansonAssistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94275, Le Kremlin-Bicêtre, France. philippe.chanson@bct.aphp.fr.ORCID http://orcid.org/0000-0001-5096-5722

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33156493
PMCPMC7835287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.